Currently Viewing:
Evidence-Based Diabetes Management April 2015
When Moving to Collaborative Care, a Challenge Is Figuring Out How to Pay for It
Mary K. Caffrey
Studies Are Showing SGLT2s Also Help Control Hypertension, Eliminate Some Side Effects
Andrew Smith
Unraveling the Mysteries and Extensive Needs of Emergency Department "Superutilizers"
Tony Hagen
What NCQA Recognition Means for Patients With Diabetes
Robert A. Gabbay, MD, PhD, FACP
A Look at the Unhealthiness of Sitting, and a Call for More Research on Its Effects
Mary K. Caffrey
TV Watching Appears Worse Than Other Forms of Sitting
Mary K. Caffrey
Study Finds Older Adults With T2DM, Comorbidities Aren't Getting Enough Treatment Time
Tony Hagen
Implementing JNC 8 Guidelines Is Generally Cost-Effective, According to NEJM Findings
Mary K. Caffrey
Weighing the Options With Bariatric Surgery: Long-Term Results Compare Risks, Health Outcomes
Surabhi Dangi-Garimella, PhD
Dietary Panel Releases Report, Cholesterol Removed From List of Nutrients to Avoid
Mary K. Caffrey
Higher-Dose Liraglutide Creates New Options to Fight Obesity, but Payment Remains a Challenge
Andrew Smith
Obesity Among Children and Teens Demands Stronger Response, Lancet Authors Find
Mary K. Caffrey
FDA Approves Toujeo, Basal Insulin Seen as Successor to Lantus
Mary K. Caffrey
Glyxambi Approved, Combo Provides Actions of SGLT2, DPP-4 Inhibitors for Patients With T2DM
Mary K. Caffrey
FDA Approves Aflibercept for Diabetic Retinopathy in Patients With Diabetic Macular Edema
Mary K. Caffrey
Panel Discusses ACA's Effect on Mental Health Delivery, Care for Those With Comorbidities
Mary K. Caffrey
Currently Reading
AMA, CDC Launch Prevent Diabetes STAT to Prevent More Cases of Type 2
Mary K. Caffrey

AMA, CDC Launch Prevent Diabetes STAT to Prevent More Cases of Type 2

Mary K. Caffrey
The president of the American Medical Association (AMA) and the director of CDC’s Division of Diabetes Translation recently launched an initiative to screen for prediabetes and promote interventions to stop its progression, with the goal of halting more cases of type 2 diabetes mellitus (T2DM). The disease threatens 1 of 3 Americans.1,2
 
Prevent Diabetes STAT—which stands for Screen, Test, Act Today—was announced March 12, 2015.It expands upon current efforts by the AMA, CDC, and partners like the YMCA to reach those with prediabetes. In a briefing with healthcare press, including Evidence-Based Diabetes Management, AMA President Robert M. Wah, MD, and CDC’s Ann Albright, PhD, RD, outlined the effort to engage physicians, employers, commercial insurers, CMS, and even the food industry in the cause.
 
Wah and Albright described the effort as improving “linkages” among all those who play a role in preventing T2DM. Albright was adamant that this could not be a short-term, government-run program with grant-based resources. “The time to act is now,” she said. “We need a national, concerted effort to prevent additional cases of type 2 diabetes, and we need it now."
 
The defined persons with prediabetes as having glycated hemoglobin (A1C) levels between 5.7 and 6.4 or fasting glucose between 100 mg/dL and 125 mg/dL. An estimated 86 million Americans have prediabetes but 90% of them don’t know it, a fact that makes it hard for physicians and public health officials to keep the population with T2DM from rising.1,2
 
The impact of diabetes is mounting. A study by the American Diabetes Association showed that the disease cost the United States $245 billion in 2012 in medical spending and lost productivity, and that number had grown by $71 million since 2007.1 “Our healthcare system simply cannot sustain the continued increases in the number of people developing diabetes,” Albright said. “Screening, testing, and referring people at risk for type 2 diabetes to evidence-based lifestyle change programs are critical to preventing or delaying new cases.”
 
Wah and Albright agreed that when persons with prediabetes are made aware of their diagnosis, especially by a physician, they typically do make lifestyle changes or take medication to get indicators like blood glucose under control. The outreach efforts to identify those at risk, therefore, are essential.
 
Prevent Diabetes STAT calls for multiple stakeholders to invest resources in reaching those with prediabetes and halting the disease, first by identifying those at risk and then by putting them through prevention programs that will help patients modify their eating patterns and increase exercise for the long haul. A key component before this rollout, Albright said, has been working with commercial insurers, CMS, and major employers to convince them that paying for diabetes prevention programs is just as cost-effective as paying for medication—and perhaps more so. “You can outeat any medication,” she said. “It is imperative that we have a foundation of lifestyle change.”
 
Health plans and accountable care organizations (ACOs) will have incentives in the next few years to embrace diabetes prevention and control, under both the Affordable Care Act and recent announcements by CMS that value-based reimbursement is on the way. The agency that is the nation’s largest payer will require that 30% of Medicare payments be value-based by 2016 and 50% be value-based by 2018.3 Already, diabetes-related measures are among the population health ratings that ACOs must track in determining Medicare reimbursement under the Medicare Shared Savings Program.4
 
The roots of this launch have been in place for some time. In 2012, CDC launched the National Diabetes Prevention Program, and Albright said it had demonstrated success with 70% of participants who were over 60 years of age. 5 Now, she said, it’s time to reach many more people on a much bigger scale. Pilot projects in 4 states have given public health officials insights into the best way to connect the clinical care setting to the community centers that will deliver education programs necessary to get people to permanently change what they eat and surround themselves with the support systems to stick with behavioral change once they complete a program.
 
Wah said the AMA’s role involves reaching physicians at every level to help them screen patients and then refer them to community centers, their local YMCA, or other places where they can gain access to the National Diabetes Prevention Program. A special website for physicians has been created as part of the initiative.6
 
“Long term, we are confident that this important and necessary work will improve health outcomes and reduce the staggering burden associated with the public health epidemic of type 2 diabetes,” he said.

REFERENCES
 
1. American Diabetes Association. Economic costs of diabetes in the United States. Diabetes Care. 2013;36:1033-1046.
 
2. New AMA, CDC initiative aims to “Prevent Diabetes STAT” [press release]. Atlanta, GA: CDC Newsroom; March 12, 2015. http://www.cdc
.gov/media/releases/2015/p0311-diabetes-stat.html.
 
3. Better, smarter, healthier: in historic announcement, HHS sets clear goals and timeline for shifting Medicare reimbursements from volume to value [press release]. Washington, DC: HHS; January 26, 2015. http://www.hhs.gov/news/press/2015pres/01/20150126a.html.
 
4. Caffrey MK. Among ACO Pioneers, data reveal diabetes performance paradox. Am J Manag Care. 2014; 20(SP18)SP.
 
5. YMCA diabetes prevention program. YMCA website. http://www.ymca.net/diabetes-prevention/.Accessed March 31, 2015. 6. Prevent Diabetes STAT Toolkit. American Medical Association website. http://www.ama-assn .org/sub/prevent-diabetes-stat/toolkit.html.Lauched March 12, 2015. Accessed March 31, 2015.
PDF
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up